Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-004227-31Phase 2Completed
Phase 2 trial of nabilone in Back disorder, musculoskeletal condition (MSK) and Spinal disease, sponsored by Dr. Philipp Becker. Primary endpoints: Coping with surgery and Pain perception. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-004227-31.